Prevalence of hepatitis C virus infection in patients hospitalised for ischemic heart disease versus controls - PRO-CARDIO-C study.

Piekarska, Anna; Mamzer-Dachnowska, Aleksandra; Kasprzak, Jaroslaw D; Peruga, Jan Z; Kaszuba, Andrzej; Berkan-Kawinska, Aleksandra

Piekarska, Anna; Mamzer-Dachnowska, Aleksandra; Kasprzak, Jaroslaw D; Peruga, Jan Z; Kaszuba, Andrzej; Berkan-Kawinska, Aleksandra.

Afiliação

Piekarska A; Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland.
Mamzer-Dachnowska A; Chair and Department of Cardiology, Medical University of Lodz, Poland.
Kasprzak JD; Chair and Department of Cardiology, Medical University of Lodz, Poland.
Peruga JZ; Chair and Department of Cardiology, Medical University of Lodz, Poland.
Kaszuba A; Department of Dermatology, Medical University of Lodz, Poland.
Berkan-Kawinska A; Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland.

Clin Exp Hepatol ; 5(2): 118-122, 2019 May.

Article em En | MEDLINE | ID: mdl-31501787

Palavras-chave

HCV treatment; anti-HCV antibody; coronary artery disease; hepatitis C; screening

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Clin Exp Hepatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google